← All stocks

ZEVRA THERAPEUTICS, INC.

ZVRA Scheduled selling only

CIK 0001434647 #2833 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$2.51M

$2.04M on a plan · $470.57K straight out of an exercise

Sold at will

$0.00

0 of 13 sales

Net

−$2.51M

$0.00 against sales at will

By person

10 insiders · 15 transactions

5.9×

Neil F. McFarlane holds 5.9 times base salary in stock. $4.31M of shares against $729.17K in salary for 2025.

Salary from the company's own proxy. The shares are what Neil F. McFarlane last reported holding, valued at $11.13, the price Common Stock was last bought or sold at on the open market here, on 14 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

McFarlane Neil F.

President and CEO

—

$1.19M (3) scheduled

−$1.19M

387,225

0.6521%

$4.31M

+674.5%

Thompson Rahsaan

Chief Legal & Compliance

—

$969.36K (4) scheduled

−$969.36K

37,569

0.0633%

$418.06K

—

Watton Corey Michael

Director

—

$138.38K (1) scheduled

−$138.38K

1,800

0.0030%

$20.03K

+80.0%

Schafer Joshua

CCO

—

$126.30K (2) scheduled

−$126.30K

62,278

0.1049%

$693.01K

+1,238%

Sangiovanni Timothy J.

SVP, Finance & Corp Controller

—

$42.99K (2) scheduled

−$42.99K

29,590

0.0498%

$329.27K

+285.5%

Quartel Adrian W

Chief Medical Officer

—

$40.04K (1) scheduled

−$40.04K

9,723

0.0164%

$108.19K

+232.6%

Clifton R. LaDuane

Former CFO & Treasurer

—

143,515

0.2417%

$1.60M

+654.2%

Bode John B

Director

—

123,400

0.2078%

$1.37M

+311.3%

Shih Alvin

Director

—

20,000

0.0337%

$222.55K

—

FAVORITO TAMARA A

Director

—

3,894

0.0066%

$43.33K

+441.6%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Bode John B

24 Mar 2026

Director

Exercised, kept

39,200

$4.89

$191.69K

Bode John B

24 Mar 2026

Director

Exercised, kept

39,200

$4.97

$194.82K

Show all 15 transactions →

What was left out

Form 4 filings counted 24

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 7

Sales straight out of an exercise 6

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 754,713

History held since 7 Sep 2016